Zhuang Lefan, Woo Jennifer, Francisco Franchesca, Bertram Rickey, Wang Shirong, Jackson Ryan, Yuan Shan
Division of Transfusion Medicine, Department of Pathology, City of Hope National Medical Center, Duarte, California, USA.
Division of Transfusion Medicine, Department of Pathology, City of Hope Orange County Lennar Foundation Cancer Center, Irvine, California, USA.
J Clin Apher. 2024 Dec;39(6):e70002. doi: 10.1002/jca.70002.
The majority of the time hematopoietic progenitor cells (HPC) are collected through leukapheresis, where anticoagulants are necessary to prevent clotting of the apheresis circuit and HPC product. Although clotting of the product is a possible rare complication surrounding the HPC cryopreservation process, there have been no reports of clotting of fresh HPC product after collection. We report a case of progressive clotting of a fresh matched unrelated donor HPC product. Upon initial receipt, thin thread-like white clots were seen in the bag. In an attempt to isolate the clot, the product was aseptically aliquoted into 50 mL syringes. Within the next 60 minutes the small clots coalesced into a pink cylindrical jelly-like blood clot surrounded by serum. In the future, an anticoagulant can be added into the product prior to isolation of the clot.
大多数情况下,造血祖细胞(HPC)通过白细胞单采术采集,在此过程中需要使用抗凝剂以防止单采回路和HPC产品凝血。虽然产品凝血是HPC冷冻保存过程中一种可能出现的罕见并发症,但尚无采集后新鲜HPC产品凝血的报道。我们报告了一例新鲜的匹配无关供体HPC产品逐渐凝血的病例。最初接收时,在袋子里看到细的线状白色凝块。为了分离凝块,将产品无菌分装到50毫升注射器中。在接下来的60分钟内,小凝块聚合成一个粉红色的圆柱形果冻状血凝块,周围是血清。未来,在分离凝块之前可向产品中添加抗凝剂。